NEPH

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

Wall Street analysts forecast NEPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NEPH is 4.50 USD with a low forecast of 4.50 USD and a high forecast of 4.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Nephros Inc revenue for the last quarter amounts to 4.42M USD, increased 35.89 % YoY.

Nephros Inc. EPS for the last quarter amounts to 0.02 USD, decreased -166.67 % YoY.

Nephros Inc (NEPH) has 31 emplpoyees as of August 13 2025.

Today NEPH has the market capitalization of 43.67M USD.